LGR5 modulators (Omeros)

N/A

Report date: 2025/03/20 15:07:14
NME

Base Information

Drug NameLGR5 modulators (Omeros)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLeucine-rich repeat-containing G-protein coupled receptor 5 modulators
TargetsLeucine-rich repeat-containing G-protein coupled receptor 5
Therapy Area/IndicationsEsophageal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOmeros Corp
China Registration ClassN/A

Develop Information

Active CompaniesOmeros Corp
Inactive CompaniesN/A
Active IndicationsEsophageal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A